1. Resume
Anderson Huang (Chih-Ming, Huang)
Email: n9847@ms27.hinet.net
Mobile phone:+886-928-791-819
Phone: +886-2-275-338-52
Nationality: Taiwan, R.O.C.
B.D.: 1978 July 26th
Gender: Male
Education:
2011-2014 Executive MBA, National Tsing-Hua University
1996-2000 Pharmacy institute, Taipei Medical University
Working experience:
Feb. 2015 – Present
Marketing Manager, HER2 franchise, Roche Pharma Taiwan
 Built up self-paid promotional model across breast cancer
portfolio, Herceptin/Perjeta/Kadcyla, to strive for double digital
growth in self-paid sectors via multi-channel approach, such as
patient assistance program, digital PR operation, financial
assessment advisor program and HCP self-paid dialogue
enhancement
 Successfully launched neoadjuvant indication of Perjeta with
comprehensive launch readiness process to ensure alignment
over product brand team
 Built up tailor-made marketer development platform for junior
subordinates to catch up expertise in marketing operation
 Built Asia-Pacific HER2 Ring, Korea/Taiwan/Japan(Chugai), to
create synergic effect across HER2 portfolio and successfully
leverage joint effort to boost brand penetration for Kadcyla and
Perjeta
Apr. 2014 – Feb. 2015
Marketing Manager, Dermatology and Immunology, Novartis Pharma Taiwan
 Prepared chronic spontaneous urticaria (CSU) indication launch
for Xolair launch in self-paid and reimbursement sector
 Led cross functional brand team in dermatology to ensure early
preparation and reimbursement dossier submission by Dec. 2014
 Developed holistic digital marketing approach, including disease
awareness website, micro film production, launch media press,

2. treatment guideline conduction, educational booklet, social media
and internet traffic optimization to address gaps of disease
awareness
 Conducted sales training program and certificate procedure to
prepare the team
 leveraged experience from top urticarial center in Germany to
build up CoE of urticaria in NTUH
 Held international CSU preceptorship to cultivate Taiwan CSU
management expertise across dermatologists and immunologists
 Conducted national symposia and medical booth to advocate
brand awareness and disease unmet needs
 Successfully launched Ilaris, first IL-1 beta antagonist, in a
extreme rare diseases, CAPS ( prevalence rate < 1/1 mio), and
was granted reimbursement from health bureau
Mar. 2013 - Apr. 2014
Global Brand Manager, Xolair®
, Novartis Basel AG
 Prepared global brand plan and facilitated local country
marketing plan review process
 Co-owned pre-launch preparation, including HEOR project, ATU
research, messages test, social listening research, KOL mapping,
patient insights focus group and blogger training
 Conducted global disease awareness campaign via digital
channel, such as skintolivein.com disease website,
CSUthebigchallenge.com HCP site, CSU tracker mobile app,
EADV twitter chat and skintolivein blogger summit
 Built localization module of global developed materials to local
countries
 Led and conducted 6 digital marketing and disease awareness
workshops for universal participants from more than 30 countries
 Coordinated global budgeting management and ensured
sufficient funding support for all cross-functional projects
Jun. 2012 - Mar. 2013
Marketing Manager, Transplant and Immunology BU, Novartis Pharma Taiwan
 Successful launched Certican in kidney and heart transplant to
reach historical high and surpass major competitor in mTOR
class, Rapamune, after 1.5 year post launch
 Rejuvenated mature brand, Neoral, in autoimmune (rheumatoid
arthritis, glomerulonephritis, psoriasis) with repositionin value
proposition to drive sales growth from 267 m NTD to 302 m NTD
 Gained extra 15 m NTD upside for Neoral via innovative market

3. access strategy to gain reimbursement without price loss
 Coached two junior marketers in osteoporosis and anti-HBV to
develop local marketing plan and optimize marketing mix
operation
 Create junior marketer academy to develop hipo talent from sales
team
 Successful applied new indication in lupus nephritis for Myfortic,
matured brand in kidney transplant, with FDA/EMA approval with
numerous global alignment and joint meeting with external
stakeholders
Dec. 2010 - Jun 2012
Senior Product Manager, Transplant and Immunology BU, Novartis Pharma Taiwan
 Conducted portfolio strategy to optimize business opportunities
among Simulect, Neoral, Myfortic and Certican and reach 19 m
USD as historical high in 2011
 Initiated Medical Marketing operational model to enhance
specialty medicine customer approach and differentiate with
competitors via real-world data concept
 Prepared new launch of Certican in kidney transplant indication
and minimized sales cannibalization among TI portfolio.
 Developed and planed for coming immunosuppressant pipeline
and initiate market research and advisory board to get market
and customer insights for pre-launch planning process
 Took the leadership of Asia Cluster Transplant team and led 6
countries to share experience and initiated cross-countries
activities or strategy to boost business opportunities
Jul. 2009 - Dec. 2010
GP Project Manager, GP business unit, Novartis Pharma Taiwan
 Launched GP specific self-paid model for Aclasta (osteoporosis)
and Sebivo (anti-HBV)
 Surpassed major competitors, Baraclude (entecavir) and
Fosamax (Alendronate), in GP sector both in osteoporosis and
anti-HBV market
 Launched seasonal flu vaccine and outsourced part of business
to MWF, a local distributor, to optimize sales outcome
 Unlooked GP anti-HBV reimbursement market with intensive
cooperation with hepatology society; expand exclusive budget
from 15 m NTD to 157 m NTD in 2010
 Being as sales manager role to build up GP sales capability in
self pay model, product knowledge, disease background and

4. detailing flow
Nov. 2008 - Jul. 2009
Product Manager, Bone & Analgesic Franchise, Novartis Pharma Taiwan
 Be responsible for Aclasta and once daily Tramadol in HP
channel.
 Executed listing project of Aclasta and Tramadol
 Communicated with local distributors to maximize business
potentials in area hospital and retain sales result of mature
brands, such as Voltaren and Miacalcic.
Apr. 2008 - Nov. 2008
Associate Product Manager, Bone & Analgesic Franchise, Novartis Pharma Taiwan
 Initiated market plan and LCM strategy to protect current
business of mature product, Voltaren and Miacalcic.
 Launched Tramadol CR and new formulation of Voltaren
(Catafast) in GP channel
 Managed distributor to maximize mature product business in all
channels.
Oct. 2007 - Apr. 2008
Associate Product Manager, Neuroscience Franchise, Novartis Pharma Taiwan
 Be in charge of Trileptal and Tegretol (anti-epilepsy drug),
repositioned Trileptal in 5 segments and renewed the
promotional messages based on new segments
 Led those two products to reach historical high in market share
by 2008( 12.7%). Successfully made differentiation between two
brands and continuously gained market share of Trileptal with
double digital growth rate (2006-2008)
 Repaired cooperationship between Novartis and Taiwan Epilepsy
Society and co-own several international congresses
Jul. 2006 - Oct. 2007
Marketing specialist, Neuroscience Franchise, Novartis Pharma Taiwan
 Executed market strategy and promotional campaigns
 Cooperated with sales team to gain market insights for marketing
planning process
Jan. 2006 - Jul. 2006
Executive sales representative, SWAT team, GM sales dept., Novartis Pharma Taiwan
 As a talent of sales team, access quickly into targeting HP in
CVM field. Dig out potential business opportunities and maximize

5. sales result in NTUH. Achieved sales target with over 10%
growth rate
Jul. 2005 - Jan. 2006
Sales associate, Bone & Dermatology Franchise, GM sales dept., Novartis Taiwan
 Executed promotional activities and initiated territory managing
plan. Achieved sales target and successfully listinged in new
product, Synvisc, in NTUH
Dec. 2004 - Jul. 2005
Sales associate, Bone Franchise, mature product business unit, Novartis Taiwan
 Executed promotional activities and initiated territory managing
plan. Achieved sales target and successfully listinged in new
product, Synvisc, in NTUH
Apr. 2002 - Dec. 2004
Sales representative, Bone specialty franchise, Eli Lilly Corp
Promoted Evista and Cialis in all channel, including MC, RH, AH, DS
and GP. Developed self-pay business model in DS and GP. Get twice
excellent sales award in 2002-2003.
Jul. 2000 - Apr. 2002 Corporal, Pharmacy dept., Military service in King-Men military
HP
Certificate (or Training course)
1. Pharmacist license
2. Stanford University: certificate in strategy initiation and implementation
3. Novartis M1 training: Training course and certificate for 1st line people manager
4. Novartis marketing college: Training course for junior marketers, including national and
international training courses
5. Novartis mini college: Initiated for sales representatives before be promoted as sales
managers
6. Roche MAX-I, MAX-II training